Margus Viigimaa

4 ta ish

Centre for Cardiovascular Medicine, North Estonia Medical Centre, Tallinn University of Technology, Tallinn, Estonia

1. Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

   Antonio J. Vallejo‐Vaz, Martina De Marco, Christophe Stevens +82

   MaqolaLipoproteins and Cardiovascular HealthAtherosclerosis20181 iqtibos

   ABIABI:AkademIndex/openalex/2018.article.000004

2. Overweight, obesity, and cardiovascular disease in heterozygous familial hypercholesterolaemia: the EAS FH Studies Collaboration registry

   Amany Elshorbagy, Antonio J. Vallejo‐Vaz, Fotios Barkas +80

   MaqolaLipoproteins and Cardiovascular HealthEuropean Heart Journal20250 iqtibos

   ABIABI:AkademIndex/openalex/2025.article.000498

3. Global survey of genetic testing methods for familial hypercholesterolaemia: a study and recommendations from the European Atherosclerosis Society Familial Hypercholesterolaemia Studies Collaboration registry

   Joana Rita Chora, Irene Karungi, Amany Elshorbagy +70

   MaqolaLipoproteins and Cardiovascular HealthEuropean Journal of Preventive Cardiology20260 iqtibos

   ABIABI:AkademIndex/openalex/2026.article.017411

4. Lipid clinics worldwide: harmonization and guidance on how to optimally organize and fund. European Atherosclerosis Society consensus statement across 55 countries and more than 500 lipid clinics

   Christian Bork, Børge G. Nordestgaard, Berit Storgaard Hedegaard +67

   MaqolaLipoproteins and Cardiovascular HealthAtherosclerosis20260 iqtibos

   ABIABI:AkademIndex/openalex/2026.article.020412